Published in
American Academy of Pediatrics, Pediatrics, Supplement_4(142), p. S253-S253, 2018
DOI: 10.1542/peds.2018-2420sss
American Association for the Advancement of Science, Science Translational Medicine, 440(10), 2018
DOI: 10.1126/scitranslmed.aao0052
Links
- ORCID
- ORCID
- American Academy of Pediatrics | PDF
- ORCID
- American Association for the Advancement of Science
Tools
PGD2/DP2 receptor activation promotes severe viral bronchiolitis by suppressing IFN- λ production
Journal article published in 2018 by
Rhiannon B. Werder 
,
Jennifer C. Simpson ,
Vivian Zhang,
Cheryl A. Steiman,
Matthew Poh,
Jason P. Lynch ,
Nick H. Hodge ,
Mark L. Smythe,
John W. Upham ,
Elizabeth Forbes-Blom,
Kirsten Spann ,
Christina Kulis,
Simon Phipps ,
Mark L. Everard,
James E. Gern
,
Jennifer C. Simpson ,
Vivian Zhang,
Cheryl A. Steiman,
Matthew Poh,
Jason P. Lynch ,
Nick H. Hodge ,
Mark L. Smythe,
John W. Upham ,
Elizabeth Forbes-Blom,
Kirsten Spann ,
Christina Kulis,
Simon Phipps ,
Mark L. Everard,
James E. Gern
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
RSV-induced prostaglandin D2 release contributes to disease severity by impairing IFN-λ production.